Category Archives: Bisphosphonates

Featured Stories
Study Links Liquid in E-Cigarette to Viral Infections

Study Links Liquid in Electronic Cigarette to Increased Risk of Viral Infections

The National Jewish Health study, links the liquid used in e-cigarettes to a higher risk of respiratory viral infections, whether the liquid contains nicotine or not.

Read More

Post -Tonsillectomy Morphine Life-Threatening in Children

Post -Tonsillectomy Morphine can be Life-Threatening in Children, Study Finds

A new study published in Pediatrics suggests that morphine can result in life-threatening respiratory problems when given to children after a tonsillectomy.

Read More

Long Island Car Crash Kills 1 Person, Injures 2 More

Long Island Car Crash Kills 1 Person, Injures 2 More

A car accident on LI left one person dead & two more critically injured. The crash occurred Monday in Deer Park on Straight Path, south of Sagamore Lane.

Read More

Government Penalizes 721 Hospitals for High Rates of Infections, Injuries

Medicare is reducing payments to 721 hospitals, one out of every seven hospitals in the nation, for having high rates of “hospital-acquired” conditions (HAC.

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Federal DePuy ASR Hip Implant Trials Likely to Start This Year

It looks as though the first trials in the DePuy ASR hip implant multidistrict litigation could begin sometime later this year. According to a report from Bloomberg News, during a status conference held yesterday in Florida, attorneys for both plaintiffs and the defense told U.S. District Judge David Katz that ...

Read More

Pennsylvania Health System Proposes Comprehensive Fracking Study

A proposed study would examine the health effects of hydraulic fracturing (fracking) drilling on the people living closest to active natural gas wells.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Conflicting Studies on Oral Bisphosphonates, Esophageal Cancer Yield Confusion

Federal drug regulators in the U.S. are currently reviewing two conflicting studies examining a possible association between oral bisphosphonates, like Fosamax, and esophageal cancer. According to a report in The Wall Street Journal, it’s difficult to discern which of the … Continue reading

Posted in Bisphosphonates, Pharmaceuticals | Tagged |

Long-Term Fosamax Use May Raise Esophageal Cancer Risk

Oral bisphosphonates, including Fosamax, may increase risks for esophageal cancer if they are used for longer than 5 years. In September 2010, a study published in the British Medical Journal found that people who had taken the oral bisphosphonates over … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Eye Disorders Another Possible Bisphosphonate Side Effect

Fosamax and other bisphosphonates used by millions of women to prevent osteoporosis may make it more likely that they will suffer anterior uveitis and scleritis, serious inflammatory eye disorders. Uveitis is inflammation of the middle layer of the eye, which … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Bisphosphonate Litigation Moving Forward, As FDA Approves Generic Boniva

The U.S. Food and Drug Administration (FDA) this week approved the first generic versions of the bisphosphonate, ibandronate (Boniva). The announcement comes just as litigation involving bisphosphonate side effect lawsuits is heating up in both state and federal courts. Ibandronate … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

National Law Firm Files 36 Fosamax Femur Fracture Lawsuits

Earlier this month, the national law firm of Parker Waichman LLP filed 36 Fosamax femur fracture lawsuits in the Fosamax side effects mass tort currently underway in New Jersey Superior Court. All of the lawsuits allege that the long-term use … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Stopping Bisphosphonates May Reduce Femur Fracture Risk

Stopping bisphosphonates, a class of osteoporosis drugs that builds bone, could reduce risks for femur fracture by half, according to growing research. The rare, but serious, thigh bone fracture, known as atypical femur fracture, has been linked to oral bisphosphonates … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Judge Refuses To Overturn Zometa Dead Jaw Verdict

A federal judge has refused to overturn a verdict Zometa dead jaw lawsuit. Previously, a jury agreed that the drug maker neglected to appropriately warn about the risks connected to its bone-strengthening medications, Zometa and Aredia, such as severe jaw … Continue reading

Posted in Bisphosphonates, Pharmaceuticals |

Fosamax, Other Osteoporosis Drugs Need Stronger Warnings, FDA Advisors Say

A panel of Food & Drug Administration (FDA) advisors said on Friday that < "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax and similar bone drugs need stronger warnings regarding duration of use because of their possible long-term risks. But the panel could not agree if use … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

Five Years on Fosamax, Other Bone Drugs May be Adequate, FDA Says

< "http://www.yourlawyer.com/topics/overview/fosamax">Fosamax, < "http://www.yourlawyer.com/topics/overview/actonel">Actonel, < "http://www.yourlawyer.com/topics/overview/Boniva">Boniva and other oral bisphosphonates don’t have to be taken beyond five years in order to prevent broken bones from osteoporosis, a new U.S. Food & Drug Administration (FDA) report says. The report was released … Continue reading

Posted in Bisphosphonates, Fosamax, Pharmaceuticals |

FDA Panel to Discuss Long-Term Use of Fosamax, other Bone Drugs

A U.S. Food & Drug Administration (FDA) advisory panel is set to examine the safety of < "http://www.yourlawyer.com/topics/overview/Bisphosphonates">oral bisphosphonates later this week. The FDA advisory panel meeting, set to start of Friday, is being convened because of concerns that long-term … Continue reading

Posted in Bisphosphonates |

© 2005-2017 Parker Waichman LLP ®. All Rights Reserved.